Project description:Influenza immunization during pregnancy provides protection to the mother and the infant. Studies in adults and children with inactivated influenza vaccine (IIV) have identified changes in immune gene expression that correlated with antibody responses. We studied changes in transcriptional profiles induced by IIV in pregnant women and to identify correlates of antibody responses.
Project description:Vaccination in pregnancy is an effective tool to protect both the mother and infant. Vaccines against tetanus, pertussis and influenza are recommended for use in pregnancy and new vaccines with specific indications for pregnancy are in the clinical trials pipeline. However our understanding of the immune response to vaccination in pregnancy is incomplete. We compared the effect of pregnancy on early (24 hours) transcriptional responses to vaccination. Pregnant mice and women were immunised with Boostrix-IPV, a vaccine containing pertussis antigens.
Project description:Despite influenza vaccination, some individuals succumb to life-threatening influenza or even death. Yet our understanding of differential immune features generated by vaccination versus infection by influenza A and influenza B viruses (IAVs, IBVs) is limited. We sought to define molecular signatures of influenza-specific B cells elicited following influenza virus infection or vaccination towards both IAV and IBV subtypes. Using barcoded fluorescently-labelled haemagglutinin (HA)-specific probes, we performed single-cell RNA sequencing of influenza-specific B cells on day 0, 7 and 28 following influenza inactivated vaccination, in comparison to hospitalized patients during acute IAVor IBV as well as at 1-month convalescence. Comparing B cell responses elicited by infection and vaccination, the most striking findings stemmed from increased interferon-stimulated gene signatures, especially IF44L, IFITM1 and XAF1, in total B cells during acute IBV infection, which decreased at 1 month following patients’ recovery. These interferon-stimulated genes were not observed in B cells following influenza vaccination encompassing both IAV and IBV components or IAV infection in our patients. For HA-specific B cells, transcriptomic analysis revealed phenotypic differentiation and isotype class-switching following vaccination, with evidence of clonal sharing between memory and atypical B cell phenotypes. In in vitro influenza virus infection experiments, IBVs showed higher infectivity of human peripheral blood mononuclear cells, including B cells, in comparison to IAVs. Additional co-culture of infected PBMCs with plasma obtained from patients hospitalized with IAV, IBV, COVID-19 and RSV increased the infectivity of immune cells by both IBV and IAV, suggesting that B cell infectivity we observed might also be driven by plasma mediators. IBV infection also resulted in reduced B cell proliferation compared to IAV, potentially associated with the antiproliferative effect of IFITM1. Our findings comparing and contrasting influenza-specific B cell responses elicited following acute influenza virus infection versus vaccination provide key insights into understanding B cell immunity towards IBV versus IAV infections, in contrast to vaccination responses, to inform rational vaccine design and therapeutic targets.
Project description:Vaccination in pregnancy is an effective tool to protect both the mother and infant. Vaccines against tetanus, pertussis and influenza are recommended for use in pregnancy and new vaccines with specific indications for pregnancy are in the clinical trials pipeline. However our understanding of the immune response to vaccination in pregnancy is incomplete. We compared the effect of pregnancy on early (24 hours) transcriptional responses to vaccination. Pregnant mice and women were immunised with Boostrix-IPV, a vaccine containing pertussis antigens.
Project description:The iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed to separate differentially expressed placental proteins from 4 pregnant women with ICP and 4 healthy pregnant women.
Project description:Breastfeeding protects against mucosal infections in infants. The underlying mechanisms through which immunity develops in human milk following maternal infection with mucosal pathogens are not well understood. We simulate mucosal influenza infection through live attenuated influenza vaccination (LAIV) and compared milk and blood immune responses to inactivated influenza vaccination (IIV). Transcriptomic analysis was performed on RNA extracted from human milk and whole blood. Differentially expressed genes (DEGs) and gene set enrichment analysis (GSEA) on days 1 and 7 post-vaccination were compared to pre-vaccination.